Ipilimumab price?

Current Pricing of Ipilimumab

Ipilimumab, also known as Yervoy, is a prescription medication used to treat certain types of skin cancer, including melanoma. The pricing of ipilimumab varies depending on the country and the specific formulation used.

List Price in the United States

According to the manufacturer's website [1], the list price of ipilimumab in the United States is around $12,500 to $15,000 for a single dose of 10mg/mL. However, the actual cost to patients may be lower due to insurance coverage and discounts offered by the manufacturer.

Insurance Coverage and Discounts

Many insurance companies, including Medicare and Medicaid, cover ipilimumab for eligible patients. Additionally, Bristol-Myers Squibb, the manufacturer of ipilimumab, offers various discounts and patient assistance programs to help make the medication more affordable for patients with financial need [2].

Comparison with Biosimilars

There are no approved biosimilars for ipilimumab available in the market. However, several biosimilar developers are in various stages of development to offer more affordable alternatives to the original medication.

Patent Expiration and Generic Competition

The patent for ipilimumab is set to expire in 2029, which may lead to the entry of generic competitors in the market [3]. Once generic competition enters the market, prices of ipilimumab may decrease, making it more accessible to patients.

Sources:

[1] Bristol-Myers Squibb. (n.d.). Yervoy (ipilimumab) injection, for intravenous use.

[2] Bristol-Myers Squibb. (n.d.). Patient Assistance Programs.

[3] DrugPatentWatch.com. (n.d.). Yervoy.